相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intratumoral heterogeneity and clonal evolution in liver cancer
Bojan Losic et al.
NATURE COMMUNICATIONS (2020)
Progress and prospects of biomarkers in primary liver cancer (Review)
Yu-Xue Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation
Rui Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
Hao Yang et al.
CANCER CELL INTERNATIONAL (2020)
SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
Yanfang Yang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis
Byul A. Jee et al.
CANCER RESEARCH (2019)
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
Imanol Zubiete-Franco et al.
EBIOMEDICINE (2019)
Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma
Sreelakshmi Kotha et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
The post-translational modification, SUMOylation, and cancer (Review)
Zhi-Jian Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Yan-Jiun Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang et al.
JOURNAL OF HEPATOLOGY (2017)
DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression
Alexis R. Barr et al.
NATURE COMMUNICATIONS (2017)
A comprehensive compilation of SUMO proteomics
Ivo A. Hendriks et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation
Jun Liu et al.
ONCOTARGET (2016)
Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression
Young San Ko et al.
BRITISH JOURNAL OF CANCER (2015)
Combining large number of weak biomarkers based on AUC
Li Yan et al.
STATISTICS IN MEDICINE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Small Ubiquitin-like Modifier (SUMO) Isoforms and Conjugation-independent Function in DNA Double-strand Break Repair Pathways
Yiheng Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol
Ting-Shuo Huang et al.
SYSTEMATIC REVIEWS (2013)
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers
Maria Lauda Tomasi et al.
HEPATOLOGY (2012)
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Jessica D. Kessler et al.
SCIENCE (2012)
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
James J. Driscoll et al.
BLOOD (2010)
Concepts in sumoylation: a decade on
Ruth Geiss-Friedlander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Genome-scale profiling of gene expression in hepatocellular carcinoma: Classification, survival prediction, and identification of therapeutic targets
JS Lee et al.
GASTROENTEROLOGY (2004)
分享论文
